# Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms

> **NCT01640522** · NA · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 261 (actual)

## Conditions studied

- Hepatocellular Carcinoma
- Primary Liver Cancer
- Bile Duct Cancer
- Pancreatic Cancer
- Gallbladder Cancer
- Colorectal Carcinoma
- Liver Metastases

## Interventions

- **OTHER:** Collaborative Care
- **OTHER:** Enhanced usual Care

## Key facts

- **NCT ID:** NCT01640522
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2013-12
- **Final completion:** 2014-12
- **Target enrollment:** 261 (ACTUAL)
- **Last updated:** 2024-12-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01640522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01640522, "Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01640522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
